{
    "organizations": [],
    "uuid": "25356cb96c3d0ca70531b2c9db60eca52786410f",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-shenzhen-weiguang-biological-produ/brief-shenzhen-weiguang-biological-products-receives-permission-of-clinical-trial-granted-by-china-fda-idUSL3N1R849D",
    "ord_in_thread": 0,
    "title": "BRIEF-Shenzhen Weiguang Biological Products ‍receives permission of clinical trial granted by China FDA",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 26 (Reuters) - Shenzhen Weiguang Biological Products Co Ltd :\n* Says it received permission of clinical trial granted by China FDA with respect to Human coagulation Factor Ⅷ\nSource text in Chinese: goo.gl/nUau5F\nFurther company coverage: (Beijing Headline News)\n ",
    "published": "2018-03-26T19:06:00.000+03:00",
    "crawled": "2018-03-27T12:12:40.015+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "shenzhen",
        "weiguang",
        "biological",
        "product",
        "co",
        "ltd",
        "say",
        "received",
        "permission",
        "clinical",
        "trial",
        "granted",
        "china",
        "fda",
        "respect",
        "human",
        "coagulation",
        "factor",
        "ⅷ",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}